Trial
NCT01632306
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
Mayo Clinic
Condition
Pancreatic Cancer
Intervention
LY2090314
Why stopped
Study has been terminated due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-15